Accomplished businessman Marc Beer has recently raised over forty million dollars for his women’s health startup. When beginning this endeavor, Beer pledged a great deal of his experience and wealth to this women’s health startup. He co-founded the startup, called Renovia Inc., to utilize his skill and background in development and commercial experience in the field of pelvic floor disorders of women.
Renovia Inc. was founded in 2016 with the aim of improving diagnosis and treatment for the millions of women that have pelvic floor disorders, hoping to advance their quality of life that has been specific to their condition in the past. Women with pelvic floor disorders, such as urinary tract incontinence, can be grateful to Renovia Inc. for its development of a product pipeline that could potentially utilize an app to visualize and diagnose pelvic movement. Renovia Inc. already boasts an FDA-cleared device called Leva, which not only strengthens pelvic floor muscles, but can also treat a woman’s stress and urinary incontinence.
The recent raising of funds for the company comes from 10 million dollars in venture debt and 32 million in Series B investment. The startup funds will be used to proceed in the research and development of several new products, which will also be aimed toward women that suffer from pelvic floor issues. The products will span from diagnostic to therapeutic means of use, and will all be geared toward solving pelvic floor issues, such as urinary incontinence, that effect over 250 million women throughout the world.
The Series B round welcomed investors such as Ascension Ventures of Missouri, Perceptive Advisors of New York, and, most recently, a healthcare-based investing firm called The Longwood Fund.
Renovia’s CEO Marc Beer states his gratitude toward the healthcare companies investments, and welcomes them on board for the upcoming testing and development. He mentions that he feels his vision of improving the lives of those women effected by pelvic disorders is shared by investors, and is looking forward to innovating the technologies and digital health platforms that will grow the data and knowledge of pelvic floor disorders. Research and gathering of information will not only provide therapeutic treatment to these women, but also has the potential to lower healthcare costs in the long run. Learn more: https://gazetteday.com/2018/10/marc-beer-funding-renovia/
The new products to be released will include four products that are involved in the therapy and diagnosis of pelvic floor disorders, one of which is a new model of the Leva device that is currently on the market from Renovia.